Activated platelet membrane vesicles for broad-spectrum bacterial pulmonary infections management
Journal of Controlled Release,
Год журнала:
2025,
Номер
380, С. 846 - 859
Опубликована: Фев. 19, 2025
Язык: Английский
The Role of Fibroblast Growth Factors in Viral Replication: FGF-2 as a Key Player
Danial Zareh,
Reyhaneh Nekounam Ghadirli,
Hao Zuo
и другие.
IntechOpen eBooks,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 24, 2025
Fibroblast
growth
factors
(FGFs)
are
crucial
signaling
proteins
that
govern
numerous
cellular
activities,
such
as
proliferation,
differentiation,
and
tissue
repair.
Recent
studies
indicate
FGFs,
particularly
FGF-2,
pivotal
in
viral
replication
by
altering
the
host
cell
environment
to
promote
survival,
replication,
immune
evasion.
Viruses
rely
on
components
for
their
often
manipulate
pathways,
including
FGF
signaling,
optimize
growth.
Among
various
FGF-2
(basic
FGF)
stands
out
influential
due
its
roles
angiogenesis,
modulation.
This
chapter
explores
molecular
processes
via
which
FGFs
affect
life
cycles,
highlighting
is
notably
important
promoting
impact
inflammation.
Understanding
FGF-mediated
may
offer
new
therapeutic
targets
infections.
Язык: Английский
A comprehensive update on the use of molecular topology applications for anti-infective drug discovery
Expert Opinion on Drug Discovery,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 8, 2025
Introduction
The
rapid
emergence
of
infectious
diseases
poses
a
significant
threat
to
global
economies
and
public
health.
To
combat
this,
it
is
crucial
develop
effective
treatments.
One
essential
tool
in
drug
design
molecular
topology,
which
uses
topological
indices
build
QSAR
models.
This
mathematical
framework
describes
chemical
compound
structures,
facilitating
easy
characterization.
Язык: Английский
Host Immunity and Intracellular Bacteria Evasion Mechanisms: Enhancing Host-Directed Therapies with Drug Delivery Systems
International Journal of Antimicrobial Agents,
Год журнала:
2025,
Номер
unknown, С. 107492 - 107492
Опубликована: Март 1, 2025
Язык: Английский
Non-antiviral therapies for viral infections: Harnessing host mechanisms
International Immunopharmacology,
Год журнала:
2025,
Номер
153, С. 114521 - 114521
Опубликована: Март 27, 2025
Язык: Английский
Metformin in Antiviral Therapy: Evidence and Perspectives
Viruses,
Год журнала:
2024,
Номер
16(12), С. 1938 - 1938
Опубликована: Дек. 18, 2024
Metformin,
a
widely
used
antidiabetic
medication,
has
emerged
as
promising
broad-spectrum
antiviral
agent
due
to
its
ability
modulate
cellular
pathways
essential
for
viral
replication.
By
activating
AMPK,
metformin
depletes
energy
reserves
that
viruses
rely
on,
effectively
limiting
the
replication
of
pathogens
such
influenza,
HIV,
SARS-CoV-2,
HBV,
and
HCV.
Its
role
in
inhibiting
mTOR
pathway,
crucial
protein
synthesis
reactivation,
is
particularly
significant
managing
infections
caused
by
CMV,
EBV.
Furthermore,
reduces
oxidative
stress
reactive
oxygen
species
(ROS),
which
are
critical
replicating
arboviruses
Zika
dengue.
The
drug
also
regulates
immune
responses,
differentiation,
inflammation,
disrupting
life
cycle
HPV
potentially
other
viruses.
These
diverse
mechanisms
suppress
replication,
enhance
system
functionality,
contribute
better
clinical
outcomes.
This
multifaceted
approach
highlights
metformin’s
potential
an
adjunctive
therapy
treating
wide
range
infections.
Язык: Английский